I Am Biotech » Bio09

Meet Dana Boyle

Emily — Thu, 07 Jan 2010 15:27:44 +0000

Dana Boyle, the Vice President of Business Development for Life Science Alley explains what Life Science Alley is, who their members are and how she became involved in biotechnology.

Meet Mike Spear

Emily — Mon, 04 Jan 2010 15:35:44 +0000

IAmBiotech interviewed Mike Spear, Communications Director of GenomeAlberta, about his company and the challenges facing biotech. Check out this brief description from GenomeAlberta’s Web site and the video interview below.

In partnership with Genome Canada Industry Canada and the Province of Alberta, Genome Alberta was established in the fall of 2005 to focus on genomics as one of the central components of the Life Sciences Initiative in Alberta, and to help position the Initiative as a core research effort.

Genome Alberta strives to be the leading source of information and administration related to genomics, proteomics, bioinformatics and bioethics research in Alberta. We are dedicated to informing students, researchers, research organizations, our partners, and the public regarding opportunities and challenges in genomics and proteomics, and in encouraging the development of a vibrant and vigorous Life Sciences research industry in Alberta.

Meet Pete Roskop

Emily — Thu, 31 Dec 2009 15:42:40 +0000

Happy New Year’s Eve everyone!

Check out this video interview of Pete Roskop from the Colorado Office of Economic Development as he describes the biotech sector in Colorado.

Science Education – Preparing the Next Leaders in Biotech

ebarboni — Wed, 16 Sep 2009 14:27:51 +0000

As middle and high school students head back to class this month, we wanted to take a look at the important issue of science education. Strong science programs are critical for preparing the next generation of innovators, and the Biotech Institute is working to ensure that students across the country have access to engaging programs that excite them about the science and its applications.

In this interview, Paul Hanle – the President of the Biotech Institute – tells us about their important work with science teachers.

Patient Advocates Turn to Biotech for Parkinson’s Treatments and Cures

ebarboni — Mon, 24 Aug 2009 21:54:11 +0000

At the 2009 BIO International Convention, IAmBiotech spoke with James Trussell from the Parkinson’s Action Network and Peggy Willocks from PD Trials about the importance of biotechnology for finding a cure for Parkinson’s Disease. We were also joined by Tricia Brooks, Managing Director for Alliance Development at the Biotechnology Industry Organization (BIO).

Patient advocates discuss the importance of biotech breakthroughs

ebarboni — Thu, 20 Aug 2009 23:03:04 +0000

At the 2009 BIO International Convention, Rod Mitchell from the International Genetic Alliance, Melissa Sossabee from the Arthritis Foundation, and Kristian Hurley from the American Autoimmune Related Diseases Association discuss why biotech innovation is so important for finding treatments and cures for the diseases they work so hard to fight.

Patient Perspective: The importance of biotech innovation for treating rare diseases

ebarboni — Tue, 18 Aug 2009 13:59:54 +0000

As we travel around the country, we meet a lot of patients with rare diseases who are counting on biotech to develop life saving cures and treatments. It provides tremendous hope for those who are battling these diseases to know the success that biotech has had in improving so many patients’ lives.

At the 2009 Bio International Convention, we spoke with Ashley Kurpiel, who is suffering from Fibrodysplasia Ossificans Progressiva (FOP) about why she believes biotech innovation is so critical for patients like her.

States See Biotech as a Winning Investment

ebarboni — Tue, 04 Aug 2009 17:00:24 +0000

At the 2009 Bio International Convention, IAmBiotech spoke with state officials from across the US about the critical role that the biotech industry plays in health, energy, agriculture and economic development.

This video features interviews with Governors Martin O’Malley (MD), Tim Kaine (VA), and Steve Beshear (KY), and other officials about why their states have invested in developing their biotech sectors.